These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17395464)

  • 1. Small molecule antagonists of the CC chemokine receptor 4 (CCR4).
    Burdi DF; Chi S; Mattia K; Harrington C; Shi Z; Chen S; Jacutin-Porte S; Bennett R; Carson K; Yin W; Kansra V; Gonzalo JA; Coyle A; Jaffee B; Ocain T; Hodge M; LaRosa G; Harriman G
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3141-5. PubMed ID: 17395464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Core exploration in optimization of chemokine receptor CCR4 antagonists.
    Purandare AV; Wan H; Somerville JE; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2007 Feb; 17(3):679-82. PubMed ID: 17098428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and SAR of trisubstituted thiazolidinones as CCR4 antagonists.
    Allen S; Newhouse B; Anderson AS; Fauber B; Allen A; Chantry D; Eberhardt C; Odingo J; Burgess LE
    Bioorg Med Chem Lett; 2004 Apr; 14(7):1619-24. PubMed ID: 15026036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of CCR4 antagonists: side-chain exploration.
    Purandare AV; Wan H; Gao A; Somerville J; Burke C; Vaccaro W; Yang X; McIntyre KW; Poss MA
    Bioorg Med Chem Lett; 2006 Jan; 16(1):204-7. PubMed ID: 16236499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and optimization of novel 3-piperazinylcoumarin antagonist of chemokine-like factor 1 with oral antiasthma activity in mice.
    Li G; Wang D; Sun M; Li G; Hu J; Zhang Y; Yuan Y; Ji H; Chen N; Liu G
    J Med Chem; 2010 Feb; 53(4):1741-54. PubMed ID: 20099827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and evaluation of naphthalene-sulfonamide antagonists of human CCR8.
    Jenkins TJ; Guan B; Dai M; Li G; Lightburn TE; Huang S; Freeze BS; Burdi DF; Jacutin-Porte S; Bennett R; Chen W; Minor C; Ghosh S; Blackburn C; Gigstad KM; Jones M; Kolbeck R; Yin W; Smith S; Cardillo D; Ocain TD; Harriman GC
    J Med Chem; 2007 Feb; 50(3):566-84. PubMed ID: 17266208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of chemokine receptor CCR4 antagonist.
    Purandare AV; Gao A; Wan H; Somerville J; Burke C; Seachord C; Vaccaro W; Wityak J; Poss MA
    Bioorg Med Chem Lett; 2005 May; 15(10):2669-72. PubMed ID: 15863339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.
    Procopiou PA; Ford AJ; Graves RH; Hall DA; Hodgson ST; Lacroix YM; Needham D; Slack RJ
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2730-3. PubMed ID: 22437117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and syntheses of 1,6-naphthalene derivatives as selective HCMV protease inhibitors.
    Gopalsamy A; Lim K; Ellingboe JW; Mitsner B; Nikitenko A; Upeslacis J; Mansour TS; Olson MW; Bebernitz GA; Grinberg D; Feld B; Moy FJ; O'Connell J
    J Med Chem; 2004 Apr; 47(8):1893-9. PubMed ID: 15055990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead identification and structure-activity relationships of heteroarylpyrazole arylsulfonamides as allosteric CC-chemokine receptor 4 (CCR4) antagonists.
    Miah AH; Copley RC; O'Flynn D; Percy JM; Procopiou PA
    Org Biomol Chem; 2014 Mar; 12(11):1779-92. PubMed ID: 24515101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of CC chemokine receptor-3 (CCR3) antagonists with picomolar potency.
    De Lucca GV; Kim UT; Vargo BJ; Duncia JV; Santella JB; Gardner DS; Zheng C; Liauw A; Wang Z; Emmett G; Wacker DA; Welch PK; Covington M; Stowell NC; Wadman EA; Das AM; Davies P; Yeleswaram S; Graden DM; Solomon KA; Newton RC; Trainor GL; Decicco CP; Ko SS
    J Med Chem; 2005 Mar; 48(6):2194-211. PubMed ID: 15771462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis.
    Revesz L; Bollbuck B; Buhl T; Eder J; Esser R; Feifel R; Heng R; Hiestand P; Jachez-Demange B; Loetscher P; Sparrer H; Schlapbach A; Waelchli R
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5160-4. PubMed ID: 16198561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of 4-amino-3,4-dihydro-2H-naphthalen-1-one derivatives as mast cell stabilising and anti-inflammatory compounds.
    Barlow JW; Walsh JJ
    Eur J Med Chem; 2008 Dec; 43(12):2891-900. PubMed ID: 18406013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hamaguchi W; Yamasaki S; Koganemaru Y; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2009 Jan; 17(1):64-73. PubMed ID: 19081254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bipiperidinyl carboxylic acid amides as potent, selective, and functionally active CCR4 antagonists.
    Kuhn CF; Bazin M; Philippe L; Zhang J; Tylaska L; Miret J; Bauer PH
    Chem Biol Drug Des; 2007 Sep; 70(3):268-72. PubMed ID: 17718722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An intracellular allosteric site for a specific class of antagonists of the CC chemokine G protein-coupled receptors CCR4 and CCR5.
    Andrews G; Jones C; Wreggett KA
    Mol Pharmacol; 2008 Mar; 73(3):855-67. PubMed ID: 18042736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3-Amino-1-alkyl-cyclopentane carboxamides as small molecule antagonists of the human and murine CC chemokine receptor 2.
    Butora G; Jiao R; Parsons WH; Vicario PP; Jin H; Ayala JM; Cascieri MA; Yang L
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3636-41. PubMed ID: 17482462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists.
    Scott JD; Miller MW; Li SW; Lin SI; Vaccaro HA; Hong L; Mullins DE; Guzzi M; Weinstein J; Hodgson RA; Varty GB; Stamford AW; Chan TY; McKittrick BA; Greenlee WJ; Priestley T; Parker EM
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6018-22. PubMed ID: 19800231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Racemic and chiral lactams as potent, selective and functionally active CCR4 antagonists.
    Newhouse B; Allen S; Fauber B; Anderson AS; Eary CT; Hansen JD; Schiro J; Gaudino JJ; Laird E; Chantry D; Eberhardt C; Burgess LE
    Bioorg Med Chem Lett; 2004 Nov; 14(22):5537-42. PubMed ID: 15482919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CCR5 receptor antagonists: discovery and SAR study of guanylhydrazone derivatives.
    Wei RG; Arnaiz DO; Chou YL; Davey D; Dunning L; Lee W; Lu SF; Onuffer J; Ye B; Phillips G
    Bioorg Med Chem Lett; 2007 Jan; 17(1):231-4. PubMed ID: 17081751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.